174 related articles for article (PubMed ID: 23681961)
1. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy.
Luetkemeyer AF; Havlir DV; Currier JS
Top Antivir Med; 2013; 21(2):62-74. PubMed ID: 23681961
[TBL] [Abstract][Full Text] [Related]
2. Complications of HIV disease and antiretroviral therapy.
Luetkemeyer AF; Havlir DV; Currier JS
Top Antivir Med; 2012; 20(2):48-60. PubMed ID: 22710907
[TBL] [Abstract][Full Text] [Related]
3. CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy.
Luetkemeyer AF; Havlir DV; Currier JS
Top Antivir Med; 2014 May; 22(2):602-15. PubMed ID: 24901886
[TBL] [Abstract][Full Text] [Related]
4. Complications of HIV disease and antiretroviral therapy.
Luetkemeyer AF; Havlir DV; Currier JS
Top Antivir Med; 2011; 19(2):58-68. PubMed ID: 21868823
[TBL] [Abstract][Full Text] [Related]
5. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic HCV genotype 1 coinfection.
Boesecke C; Rockstroh JK
Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
Bräu N
J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
[TBL] [Abstract][Full Text] [Related]
9. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
[TBL] [Abstract][Full Text] [Related]
10. CROI 2016: Viral Hepatitis and Liver Fibrosis.
Luetkemeyer AF; Wyles DL
Top Antivir Med; 2016; 24(1):47-58. PubMed ID: 27398862
[TBL] [Abstract][Full Text] [Related]
11. Management of acute and chronic HCV infection in persons with HIV coinfection.
Sulkowski MS
J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
[TBL] [Abstract][Full Text] [Related]
12. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Goebel FD; Jablonowski H
Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
[TBL] [Abstract][Full Text] [Related]
13. Are there any challenges left in hepatitis C virus therapy of HIV-infected patients?
Bischoff J; Rockstroh JK
Int J Antimicrob Agents; 2020 Jul; 56(1):105527. PubMed ID: 30145247
[TBL] [Abstract][Full Text] [Related]
14. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
Neukam K; Morano-Amado LE; Rivero-Juárez A; Mancebo M; Granados R; Téllez F; Collado A; Ríos MJ; de Los Santos-Gil I; Reus-Bañuls S; Vera-Méndez F; Geijo-Martínez P; Montero-Alonso M; Suárez-Santamaría M; Pineda JA
HIV Clin Trials; 2017 May; 18(3):126-134. PubMed ID: 28599618
[TBL] [Abstract][Full Text] [Related]
15. A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Braun DL; Rauch A; Aouri M; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Müllhaupt B; Metzner KJ; Decosterd L; Böni J; Weber R; Fehr J;
PLoS One; 2015; 10(7):e0133028. PubMed ID: 26176696
[TBL] [Abstract][Full Text] [Related]
16. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
[TBL] [Abstract][Full Text] [Related]
17. Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.
Miailhes P; Hartig-Lavie K; Virlogeux V; Pradat P; Diakite M; Uhres AC; Zoulim F; Sarda MN
Clin Microbiol Infect; 2018 Nov; 24(11):1215.e1-1215.e4. PubMed ID: 29870852
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients.
De Leon LB; Tovo CV; Kliemann DA; De Mattos AA; Feltrin AA; Pacheco LS; De Almeida PR
J Infect Dev Ctries; 2016 Aug; 10(7):762-9. PubMed ID: 27482809
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.
Uriarte-Pinto M; Navarro-Aznarez H; De La Llama-Celis N; Arazo-Garcés P; Martínez-Sapiña AM; Abad-Sazatornil MR
Int J Clin Pharm; 2018 Jun; 40(3):608-616. PubMed ID: 29556931
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of HIV/HCV coinfection in adults.
Schlabe S; Rockstroh JK
Expert Opin Pharmacother; 2018 Jan; 19(1):49-64. PubMed ID: 29252031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
